NWAM LLC’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $501K | Sell |
13,597
-1,809
| -12% | -$66.7K | 0.04% | 331 |
|
|
2025
Q1 | $455K | Buy |
15,406
+309
| +2% | +$9.12K | 0.04% | 333 |
|
|
2024
Q4 | $439K | Sell |
15,097
-14,565
| -49% | -$424K | 0.03% | 401 |
|
|
2024
Q3 | $1.36M | Buy |
29,662
+5,746
| +24% | +$264K | 0.08% | 218 |
|
|
2024
Q2 | $977K | Sell |
23,916
-3,446
| -13% | -$141K | 0.29% | 56 |
|
|
2024
Q1 | $695K | Sell |
27,362
-1,959
| -7% | -$49.7K | 0.06% | 274 |
|
|
2023
Q4 | $265K | Sell |
29,321
-6,372
| -18% | -$57.7K | 0.02% | 465 |
|
|
2023
Q3 | $228K | Buy |
35,693
+4,928
| +16% | +$31.4K | 0.02% | 448 |
|
|
2023
Q2 | $341K | Buy |
30,765
+9,265
| +43% | +$103K | 0.03% | 389 |
|
|
2023
Q1 | $330K | Buy |
21,500
+3,759
| +21% | +$57.7K | 0.03% | 345 |
|
|
2022
Q4 | $394K | Sell |
17,741
-2,000
| -10% | -$44.4K | 0.03% | 356 |
|
|
2022
Q3 | $322K | Hold |
19,741
| – | – | 0.03% | 372 |
|
|
2022
Q2 | $337K | Hold |
19,741
| – | – | 0.03% | 386 |
|
|
2022
Q1 | $365K | Buy |
19,741
+1,087
| +6% | +$20.1K | 0.03% | 379 |
|
|
2021
Q4 | $443K | Sell |
18,654
-2,100
| -10% | -$49.9K | 0.04% | 351 |
|
|
2021
Q3 | $511K | Sell |
20,754
-1,900
| -8% | -$46.8K | 0.05% | 320 |
|
|
2021
Q2 | $560K | Sell |
22,654
-9,267
| -29% | -$229K | 0.05% | 291 |
|
|
2021
Q1 | $696K | Buy |
+31,921
| New | +$696K | 0.07% | 254 |
|